In BM compared with the primary tumor site from patients, less infiltration of T lymphocytes (tumor-infiltrating lymphocytes) [106] and lower expression of PDL-1 with higher expression of HLA-1 and PDL-2 have been reported. This evidence concerns the gene PDCD1LG2 and neoplasm.